Metabolism of chylomicron-like emulsions in patients with Hodgkin's and with non-Hodgkin's lymphoma

Leukemia Research

Volumn 27, Issue 2, 2003, Pages 147-153

  Gonçalves, Romélia P ^a   Hungria, Vânia T M ^a   Chiattone, Carlos S ^a   Pozzi, Diana B ^a   Maranhão, Raul C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cholesterol metabolism; Lipolysis; Lipoprotein metabolism; Lipoproteins and cancer; Triglycerides

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; CHYLOMICRON; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CALCULATION; CATABOLISM; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMULSION; FEMALE; HODGKIN DISEASE; HUMAN; KINETICS; LIPOLYSIS; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN METABOLISM; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0037298448     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(02)00087-5     Document Type: Article

References (28)

1. Ho Y.K., Smith G.L., Brown M.S., Goldstein J.L. Low-density lipoprotein (LDL) receptor activity in human acute myelogenous leukemia cells. Blood. 52:1978;1099.
2. Gal D., Ohashi M., MacDonald P.C., Buchsbaum H.J., Simpson E.R. Low-density lipoprotein as a potential vehicle for chemotherapeutic agents and radionucleotides in the management of gynecologic neoplasms. Am. J. Obstet. Gynecol. 139:1981;877.
3. Masquelier M., Vitols S., Peterson C. Low-density lipoprotein as a carrier of antitumoral drugs: in vivo fate of drug-human low-density lipoprotein complexes in mice. Cancer Res. 46:1987;3842.
4. Henriksson P., Ericsson S., Stege R., Ericsson M., Rudling M., Berglund L., Angelin B. Hypocholesterolaemia and increased elimination of low-density lipoproteins in metastatic cancer of the prostate. Lancet. II(8673):1989;1178.
5. Maranhão R.C., Garicochea B., Silva E.L., Llacer P.D., Cadena S.M.S., Coelho I.C.et al. Plasma kinectics and biodistribution of a lipid emulsion resembling low-density lipoprotein in patients with acute leukemia. Cancer Res. 54:1994;1.
6. Rudling J.M., Stahle L., Peterson C.O., Skoog L. Content of low density lipoprotein receptors in breast cancer tissue related to survival of patients. Br. Med. J. 292:1986;580.
7. Mahley R.W., Ji G.Z. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J. Lipid. Res. 40:1989;16.
8. Cooper A.D. Hepatic uptake of chylomicron remnants. J. Lipid. Res. 38:1997;2173.
9. Hungria V.T., Brandizzi L.I., Chiattone C.S., Bydlowski S.P., Maranhao R.C. Metabolism of an artificial emulsion resembling chylomicrons in patients with multiple myeloma. Leuk. Res. 23:1999;637.
10. Sakashita A.M., Bydlowski S.P., Chamone D.A., Maranhao R.C. Plasma kinetics of an artificial emulsion resembling chylomicrons in patients with chronic lymphocytic leukemia. Ann. Hematol. 79:2000;687.
11. Redgrave T.G., Maranhão R.C. Metabolism of protein-free lipid emulsion models of chylomicrons in rats. Biochim. Biophys. Acta. 835:1985;104.
12. Redgrave T.G., Ly H.L., Quintao E.C., Ramberg C.F., Boston R.C. Clearance from plasma of triacylglycerol and cholesteryl ester after intravenous injection of chylomicron-like lipid emulsions in rats and man. Biochem. J. 290:1993;843.
13. Nakandakare E.R., Lottenberg S.A., Oliveira H.C.F., Bertolami M.C., Vasconcelos K.S., Sperotto G.et al. Simultaneous measurements of chylomicron and remnant removal using a doubly labelled artificial lipid emulsion: studies in normolipidemic and hyperlipidemic subjects. J. Lipid. Res. 35:1994;143.
14. Maranhão R.C., Feres M.C., Martins M.T., Mesquita C.H., Toffoletto O., Vinagre C.G.et al. Plasma kinetics of a chylomicron-like emulsion in patients with coronary artery disease. Atherosclerosis. 126:1996;15.
15. Silva H.B., Toffoletto O., Bortolotto L.A., Latrilha M.C., Krieger E.M., Pileggi F.et al. Malignant hypertension is accompanied by marked alterations in chylomicron metabolism. Hypertension. 26:1995;1207.
16. Vinagre C.G., Stolf N.A., Bocchi E., Maranhão R.C. Chylomicron metabolism in patients submitted to cardiac transplantation. Transplantation. 69:2000;532.
17. Borba E.F., Bonfa E., Vinagre C.G., Ramires J.A.F., Maranhão R.C. Chylomicron metabolism is markedly altered in systemic lupus erythematosus. Arthritis Rheumatism. 43:1999;1033.
18. Sposito A.C., Maranhao R.C., Vinagre C.G., Santos R.D., Ramires J.A.F. Effects of etofibrate upon the metabolism of chylomicron-like emulsions in patients with coronary artery disease. Atherosclerosis. 154:2001;455.
19. Santos R.D., Ventura L.I., Sposito A.C., Schreiber R., Ramires J.A.F., Maranhao R.C. The effects of gemfibrozil upon the metabolism of chylomicron-like emulsions in patients with endogenous hypertriglyceridemia. Cardiovasc. Res. 49:2001;456.
20. Santos R.D., Sposito A.C., Ventura L.I., Cesar L.A.M., Ramires J.A.F., Maranhão R.C. Effect of pravastatin on removal of plasma from a chylomicron-like emulsion in men with coronary artery disease. Am. J. Cardiol. 85:2000;1163.
21. McKelvey E.M., Gottlieb J.A., Wilson H.E., Haut A., Talley R.W., Stephens R.et al. Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma. Cancer. 38:1976;1484.
22. Roeser H.P., Hocker G.A., Kynaston B., Roberts S.J., Whitaker S.V. Advanced non-Hodgkin's lymphomas: response to treatment with combination chemotherapy and factors influencing prognosis. Br. J. Haematol. 30:1975;233.
23. Friedewald W.T., Levy R.I., Fredrickson D.D. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18:1972;499.
24. Enerback S., Gimble J.M. Lipoprotein lipase gene expression: physiological regulation at the transcriptional and post-transcriptional level. Biochim. Biophys. Acta. 1169:1993;107.
25. Semb H., Peterson J., Tavernier J., Olivecrona T. Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo. J. Biol. Chem. 262:1987;8390.
26. Enholm C., Aho K., Huttunon J.K., Kostiainenen E., Matilla K., Pikkarainen J. Effect of interferon on plasma lipoproteins and on the activity of post-heparin lipases. Arteriosclerosis. 2:1982;68.
27. Kurzrock R., Rohde M.F., Quesada J.R., Giamturco S.H., Bradley W.A., Sherwin S.A.et al. Recombinant gamma-interferon induced hypertriglyceridemia and inhibits post-heparin lipase activity in cancer patients. J. Exp. Med. 154:1986;1093.
28. Beutler B.A., Cerami A. Recombinant interleukin 1 supresses lipoprotein lípase activity in 3T3-L1 cells. J. Immunol. 135:1985;3969.